CD86 and pleural cancer: Correspondingly, flow cytometry analysis and immunohistochemistry staining of pleural cancer nodules both demonstrated an increase in the CD86+ subset and a decrease in CD206+ subset (Fig. 2C, D, K and Figure S2C-E).